201. Age-Stratified Seroprevalence of Respiratory Syncytial Virus: Analysis Using Prefusion F and G Protein Antibodies.
- Author
-
Nham, Eliel, Jang, A-Yeung, Hyun, Hakjun, Yoon, Jin Gu, Noh, Ji Yun, Cheong, Hee Jin, Kim, Woo Joo, Ahn, Ki Bum, Ji, Hyun Jung, Seo, Ho Seong, Bae, Joon-Yong, Park, Man-Seong, and Song, Joon Young
- Subjects
RESPIRATORY syncytial virus ,G proteins ,RESPIRATORY syncytial virus infections ,RESPIRATORY syncytial virus infection vaccines ,SEROPREVALENCE - Abstract
This is a cross-sectional serosurveillance study for RSV. Between June and September of 2021, a total of 150 sera were collected from 30 individuals in each age group (<5, 5–18, 19–49, 50–64, and ≥65 years). Seroprevalence was estimated using enzyme-linked immunosorbent assays targeting two stabilized prefusion F (preF; DS-Cav1 and SC-TM) and G proteins. The overall seroprevalence was low in young children and older adults, despite them having a higher risk of severe RSV infection. There was a remarkable difference in age-stratified seroprevalence rates between anti-preF and anti-G protein antibodies. Given the high disease burden and low seroprevalence in both infants and old adults, RSV vaccination would be crucial for pregnant women and people aged over 60 years. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF